Rapid thrombosis test FRDD 025

D-dimerplasmafluorescence immunoassay

The FREND™ D-Dimer is designed for in-vitro quantitative measurement of Fibrin degradation products (FbDP, D-Dimer) in human plasma (sodium citrate) by fluorescence immunoassay. KEY FEATURES & BENEFITS - Fast and accurate test result - To diagnose DVT(Deep Vein Thrombosis) or PE(Pulmonary Embolism) - Point-Of-Care Testing which allows for better immediate clinical management decisions D-Dimer is a fibrin degradation product (or FDP), a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. The concentration of D-Dimer may be determined by a blood test to help diagnose thrombosis. It is used in the diagnosis of DVT (Deep Vein Thrombosis), PE (Pulmonary Embolism). Its main use is to exclude thromboembolic disease where the probability is low. In addition, it is used in the diagnosis of the blood disorder disseminated intravascular coagulation. Instructions for use The FREND D-Dimer is designed for use with the FREND System. The FREND System is a Point-Of-Care Testing (POCT) that uses microfluidic and immunofluorescence technology. With a simple 3 step operation and a wide range of disease markers, it supports quick decision-making. High correlation value Accuracy and Precision The FREND D-Dimer shows a high correlation compared to a predicate device and provides accurate results. Storage temperature 2 ~ 8 °C Expiration date 12 month Package 25 tests AMR 50 ~ 10,000 ng/mL FEU